We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
11 hedge funds and large institutions have $875K invested in Plus Therapeutics in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
120% more funds holding
Funds holding: 5 → 11 (+6)
59% more capital invested
Capital invested by funds: $552K → $875K (+$323K)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
11
Holders Change
+6
Holders Change %
+120%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$168K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$58.2K |
| 3 |
VF
Virtu Financial
New York
|
+$56.2K |
| 4 |
Two Sigma Investments
New York
|
+$42.7K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$8.73K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$127K |